ezogabine has been researched along with nalorphine in 1 studies
Studies (ezogabine) | Trials (ezogabine) | Recent Studies (post-2010) (ezogabine) | Studies (nalorphine) | Trials (nalorphine) | Recent Studies (post-2010) (nalorphine) |
---|---|---|---|---|---|
383 | 26 | 241 | 1,134 | 41 | 6 |
Protein | Taxonomy | ezogabine (IC50) | nalorphine (IC50) |
---|---|---|---|
Delta-type opioid receptor | Mus musculus (house mouse) | 0.1095 | |
Delta-type opioid receptor | Rattus norvegicus (Norway rat) | 0.004 | |
Kappa-type opioid receptor | Mus musculus (house mouse) | 0.1095 | |
Mu-type opioid receptor | Rattus norvegicus (Norway rat) | 0.004 | |
Kappa-type opioid receptor | Rattus norvegicus (Norway rat) | 0.004 | |
Mu-type opioid receptor | Mus musculus (house mouse) | 0.1095 | |
Beta-2 adrenergic receptor | Cavia porcellus (domestic guinea pig) | 0.006 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chang, TK; Ensom, MH; Kiang, TK | 1 |
1 review(s) available for ezogabine and nalorphine
Article | Year |
---|---|
UDP-glucuronosyltransferases and clinical drug-drug interactions.
Topics: Clinical Trials as Topic; Drug Interactions; Enzyme Activation; Enzyme Induction; Glucuronides; Glucuronosyltransferase; Humans; Pharmaceutical Preparations; Pharmacogenetics; Polymorphism, Genetic | 2005 |